BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 18636296)

  • 1. Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases.
    Zorzi D; Chun YS; Madoff DC; Abdalla EK; Vauthey JN
    Ann Surg Oncol; 2008 Oct; 15(10):2765-72. PubMed ID: 18636296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab.
    Aussilhou B; Dokmak S; Faivre S; Paradis V; Vilgrain V; Belghiti J
    Ann Surg Oncol; 2009 Jun; 16(6):1553-9. PubMed ID: 19363584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases.
    Simoneau E; Aljiffry M; Salman A; Abualhassan N; Cabrera T; Valenti D; El Baage A; Jamal M; Kavan P; Al-Abbad S; Chaudhury P; Hassanain M; Metrakos P
    HPB (Oxford); 2012 Jul; 14(7):461-8. PubMed ID: 22672548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy does not impair liver regeneration following hepatectomy or portal vein embolization for colorectal cancer liver metastases.
    Simoneau E; Alanazi R; Alshenaifi J; Molla N; Aljiffry M; Medkhali A; Boucher LM; Asselah J; Metrakos P; Hassanain M
    J Surg Oncol; 2016 Mar; 113(4):449-55. PubMed ID: 26955907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases.
    Deshayes E; Piron L; Bouvier A; Lapuyade B; Lermite E; Vervueren L; Laurent C; Pinaquy JB; Chevallier P; Dohan A; Rode A; Sengel C; Guillot C; Quenet F; Guiu B
    BMC Cancer; 2020 Jun; 20(1):574. PubMed ID: 32560632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of chemotherapy on liver regeneration induced by portal vein embolization or first hepatectomy of a staged procedure for colorectal liver metastases.
    Tanaka K; Kumamoto T; Matsuyama R; Takeda K; Nagano Y; Endo I
    J Gastrointest Surg; 2010 Feb; 14(2):359-68. PubMed ID: 19888636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal vein embolisation prior to hepatic resection for colorectal liver metastases and the effects of periprocedure chemotherapy.
    Beal IK; Anthony S; Papadopoulou A; Hutchins R; Fusai G; Begent R; Davies N; Tibballs J; Davidson B
    Br J Radiol; 2006 Jun; 79(942):473-8. PubMed ID: 16714748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined portal vein embolization and preoperative chemotherapy prior to liver resection for colorectal cancer metastases.
    Spelt L; Norman P; Törnqvist L; Tingstedt B; Andersson R
    Scand J Gastroenterol; 2012 Sep; 47(8-9):975-83. PubMed ID: 22631611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases.
    Jaeck D; Oussoultzoglou E; Rosso E; Greget M; Weber JC; Bachellier P
    Ann Surg; 2004 Dec; 240(6):1037-49; discussion 1049-51. PubMed ID: 15570209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic vein embolization after portal vein embolization to induce additional liver hypertrophy in patients with metastatic colorectal carcinoma.
    Niekamp AS; Huang SY; Mahvash A; Odisio BC; Ahrar K; Tzeng CD; Vauthey JN
    Eur Radiol; 2020 Jul; 30(7):3862-3868. PubMed ID: 32144462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative chemotherapy with bevacizumab and liver resection for colorectal cancer liver metastasis.
    Chaudhury P; Hassanain M; Bouganim N; Salman A; Kavan P; Metrakos P
    HPB (Oxford); 2010 Feb; 12(1):37-42. PubMed ID: 20495643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival and disease recurrence following portal vein embolisation prior to major hepatectomy for colorectal metastases.
    Pamecha V; Glantzounis G; Davies N; Fusai G; Sharma D; Davidson B
    Ann Surg Oncol; 2009 May; 16(5):1202-7. PubMed ID: 19130138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases.
    Covey AM; Brown KT; Jarnagin WR; Brody LA; Schwartz L; Tuorto S; Sofocleous CT; D'Angelica M; Getrajdman GI; DeMatteo R; Kemeny NE; Fong Y
    Ann Surg; 2008 Mar; 247(3):451-5. PubMed ID: 18376189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous percutaneous right portal vein embolization and left liver tumor radiofrequency ablation prior to a major right hepatic resection for bilateral colorectal metastases.
    Elias D; Santoro R; Ouellet JF; Osmak L; de Baere T; Roche A
    Hepatogastroenterology; 2004; 51(60):1788-91. PubMed ID: 15532827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sinusoidal obstruction syndrome compromises liver regeneration in patients undergoing two-stage hepatectomy with portal vein embolization.
    Narita M; Oussoultzoglou E; Chenard MP; Rosso E; Casnedi S; Pessaux P; Bachellier P; Jaeck D
    Surg Today; 2011 Jan; 41(1):7-17. PubMed ID: 21191686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative portal vein embolization for extended hepatectomy.
    Hemming AW; Reed AI; Howard RJ; Fujita S; Hochwald SN; Caridi JG; Hawkins IF; Vauthey JN
    Ann Surg; 2003 May; 237(5):686-91; discussion 691-3. PubMed ID: 12724635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portal vein embolization does not affect the long-term survival and risk of cancer recurrence among colorectal liver metastases patients: A prospective cohort study.
    Collin Y; Paré A; Belblidia A; Létourneau R; Plasse M; Dagenais M; Turcotte S; Martel G; Roy A; Lapointe R; Vandenbroucke-Menu F
    Int J Surg; 2019 Jan; 61():42-47. PubMed ID: 30537548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer.
    Gruenberger B; Tamandl D; Schueller J; Scheithauer W; Zielinski C; Herbst F; Gruenberger T
    J Clin Oncol; 2008 Apr; 26(11):1830-5. PubMed ID: 18398148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils.
    Madoff DC; Abdalla EK; Gupta S; Wu TT; Morris JS; Denys A; Wallace MJ; Morello FA; Ahrar K; Murthy R; Lunagomez S; Hicks ME; Vauthey JN
    J Vasc Interv Radiol; 2005 Feb; 16(2 Pt 1):215-25. PubMed ID: 15713922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases.
    Capussotti L; Muratore A; Baracchi F; Lelong B; Ferrero A; Regge D; Delpero JR
    Arch Surg; 2008 Oct; 143(10):978-82; discussion 982. PubMed ID: 18936377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.